Skip to content
etf.net

Launched · SEC filings

iShares Global Healthcare ETF

IXJNYSE ArcaiSharesB

$112.57−0.09 (−0.08%)

At close: Nov 2, 2026, 4:00 PM ET

B69/ 100

Rank 6 of 25 in Health Care (Broad)

B69/100Rank 6 of 25inHealth Care (Broad)
Intraday session: down, 79 prints from 112.66 to 112.57. Range 111.82 to 112.83. Use the arrow keys to read each point.111.80112.00112.20112.40112.8010 AM12 PM2 PM4 PM
Expense ratio
0.38%
Fund size
$4.65B
1Y total return
+25.5%
Yield · Last 12 months
1.28%
Holdings
123
Avg volume · 30D
240K sh
52W range
low $82.16high $114.06
Launched
Filings
SEC EDGAR

The ETF.net IXJ Grade

Based on 5 of 6 pillars

B

Score 69 out of 100

Category
Health Care (Broad)⁠
Rank
6 of 25
Six-pillar profile for IXJ. Scores out of 100: Cost 69, Risk 73, Mission not scored, Tradability 66, Holdings 66, Durability 88. Strongest: Durability (88). Weakest: Holdings (66). Based on 5 of 6 pillars.

Score 69 of 100 falls in the B band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    B69 out of 100
    Rank 7 of 25

  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored

  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    A73 out of 100
    Rank 8 of 25

  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    B66 out of 100
    Rank 8 of 25

  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    B66 out of 100
    Rank 11 of 25

  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    A88 out of 100
    Rank 2 of 25

Our read on IXJ

ETF.net Research

In short

BMost healthcare sector funds stop at the US border. IXJ tracks a global index instead: roughly 110 drugmakers, biotechs and device makers worldwide, and it has been doing it since 2001.

Stated mandate

The fund seeks to track an index of global healthcare-sector equities, offering diversified access to pharmaceutical, biotech, and medical-device companies worldwide.

Why people hold it

  • Global by charter. It tracks S&P's capped global health care index, so companies listed outside the US sit in the same basket as the American giants.ishares.com
  • 0.38% a year, below the median fee in its broad healthcare peer group, for a portfolio of about 110 pharma, biotech and medical-device names.
  • The word capped in the index name does real work: it limits how large any single mega-cap drugmaker can grow inside the fund.ishares.com
  • Running since 2001 and now a multi-billion-dollar fund. That is a long operating record, not a launch-and-see product.

Worth knowing

  • The worldwide reach carries a price tag: peers XLV and FHLC (0.08%) and VHT (0.09%) charge a fraction of IXJ's 0.38%.
  • One sector, one storyline. Patent cliffs, trial data and drug-pricing politics tend to move the whole basket at once.
  • Trading is moderate rather than heavy, so bid-ask spreads are worth a glance on larger orders.

IXJ Performance

Launched Nov 13, 2001

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

IXJ$12,547
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,199
Oct 31, 2025 to Oct 30, 2026. IXJ $12,547. SPY $11,199. Use the arrow keys to read each point.$10,000$11,000$12,000Oct 2025Apr 2026Oct 2026

Oct 31, 2025 – Oct 30, 2026

Returns run to the Oct 30, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for IXJ. Periods over one year show the average yearly return.
PeriodIXJ
Year to date+16.7%
1 month+10.3%
3 months+12.4%
1 year+25.5%
3 yearsper year+14.1%
5 yearsper year+6.7%
10 yearsper year+10.8%

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for IXJ
YearReturn barIXJ
2026 YTD+16.7%
2025+15.0%
2024+0.6%
2023+3.6%
2022−4.9%
2021+19.6%
2020+12.7%

IXJ in the news

IXJ Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 30, 2026.
1.28%Last 12 months
Payout per share
$1.44Last 12 months
Last payment
$0.85 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Twice a year

Distribution history

2017–2026

One bar per payment. 20 payments from 2017 to 2026 YTD. Jun 20, 2017 $0.49; Dec 21, 2017 $0.33; Jun 19, 2018 $0.52; Dec 18, 2018 $0.35; Dec 28, 2018 $0.33; Jun 17, 2019 $0.50; Dec 16, 2019 $0.48; Jun 15, 2020 $0.53; Dec 14, 2020 $0.44; Jun 10, 2021 $0.53; Dec 13, 2021 $0.48; Jun 9, 2022 $0.55; Dec 13, 2022 $0.44; Jun 7, 2023 $0.64; Dec 20, 2023 $0.56; Jun 11, 2024 $0.67; Dec 17, 2024 $0.62; Jun 16, 2025 $0.76; Dec 16, 2025 $0.60; Jun 15, 2026 $0.85. Use the arrow keys to read each point.2017201820192020202120222023202420252026YTD
Ex-datePay dateAmount per share
Jun 15, 2026Jun 18, 2026$0.85
Dec 16, 2025Dec 19, 2025$0.60
Jun 16, 2025Jun 20, 2025$0.76
Dec 17, 2024Dec 20, 2024$0.62
Jun 11, 2024Jun 17, 2024$0.67
Dec 20, 2023Dec 27, 2023$0.56
Jun 7, 2023Jun 13, 2023$0.64
Dec 13, 2022Dec 19, 2022$0.44
Jun 9, 2022Jun 15, 2022$0.55
Dec 13, 2021Dec 17, 2021$0.48
Jun 10, 2021Jun 16, 2021$0.53
Dec 14, 2020Dec 18, 2020$0.44

See all 46 payments⁠

$10,000 in IXJ 10 years ago paid $2,383 in dividends.⁠

IXJ Risk

Risk pillarA73 out of 100Rank 8 of 25 in Health Care (Broad)
How much the fund’s monthly returns vary, scaled to a year.
14.2%
Annualised · 36 months to Oct 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.69
vs 3-month T-bills · to Oct 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−18.1%
Trough May 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.55
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

IXJ Cost

Compare IXJ and XLV

Overpaying vs XLV, cheapest in Health Care (Broad)

$6,017

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • IXJ 0.38%

    $7,706

  • XLV 0.08% Cheapest

    $1,689

$10,000
30 years

Cost over time

  • IXJ 0.38%
  • XLV 0.08%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$2K$4K$6K$8K051015202530IXJ $7,706XLV $1,689

Year by year

YearIXJXLVOverpaying
10$688$147$541
20$2,658$575$2,083
30$7,706$1,689$6,017

Other funds in Health Care (Broad)

See others